Goldstein: Expect More Litigation After Myriad

June 13 (Bloomberg Law) -- Tom Goldstein, partner at Goldstein & Russell, PC and founder of SCOTUSblog, talks with Bloomberg Law's Lee Pacchia about the United States Supreme Court's decision in the Association for Molecular Pathology v. Myriad Genetics, Inc. case. At issue was whether patents may be granted on parts of the human body. He also explores whether Justice Scalia's concurrence raises doubts whether he believes in molecular biology, and where patent litigation will head in the wake of the decision. Bloomberg Law is a sponsor of SCOTUSblog.

Are Cloud Robotics Are a Game-Changer?
02:21 - “The Industries of the Future” Author Alec Ross discusses cloud robotics and the future of robot technology on “Bloomberg West.” (Source: Bloomberg)
  • Is There a Tech Talent Shortage in Silicon Valley?
  • Blackberry Cuts Jobs in Push to Profit
  • Bloomberg Businessweek: The Female Solidarity